Abstract

There is evidence from the empirical sciences that >happiness= B understood in the social scientists= sense of >positive affect=B leads to prosocial behaviour: the happiest amongst us are more likely to help others. There is also scientific evidence of a genetic component to positive affect: genetic differences can account for some of the observed variances in positive affect. Let us think of >happy-people-pills= as pharmacological agents, modeled on those with a genetic predisposition for high levels of positive affect, which will promote positive moods and emotions in >normally= happy persons. It is argued that if we want to increase prosocial behaviour then we should (other things being equal) promote the use of happy-people-pills. Since we should increase prosocial behaviour, we should (other things being equal) promote the use of happy-people-pills. In a short paper like this, I cannot possibly show that everything else is equal. However, I hope to establish at least a prima facie case for policy that permits the creation and distribution of happy-people-pills